RECRUITINGOBSERVATIONAL
Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
Observational Study of the HemoCept Device During Right Heart Catheterization at Boulder Heart
About This Trial
The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.
Who May Be Eligible (Plain English)
Who May Qualify:
- Subjects or representatives must have voluntarily signed the willing to sign a consent form form before any study related procedures.
- Subjects can be any gender but must be age 18 or older.
- Subject is able and willing to provide willing to sign a consent form and HIPAA authorization.
- Subject is able and willing to meet all study requirements.
- Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible)
Who Should NOT Join This Trial:
- Subject is pregnant, breastfeeding, or intends to become pregnant during this study.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.
* Subjects can be any gender but must be age 18 or older.
* Subject is able and willing to provide informed consent and HIPAA authorization.
* Subject is able and willing to meet all study requirements.
* Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible)
Exclusion Criteria:
* Subject is pregnant, breastfeeding, or intends to become pregnant during this study.
Locations (1)
Boulder Heart
Boulder, Colorado, United States